Titles and Roles
- Assistant Professor, Department of Radiation Oncology
- Emory University School of Medicine
Sibo Tian, MD, is an Assistant Professor in the Department of Radiation Oncology at Emory University School of Medicine. Dr. Tian practices general radiation oncology and specializes in the treatment of lung cancer, head and neck cancer, and sarcoma. He treats patients at Emory University Hospital Midtown and Emory Proton Therapy Center.
Dr. Tian is a member of multiple professional organizations including American Society for Radiation Oncology, American Society of Clinical Oncology, and International Association for the Study of Lung Cancer.
Dr. Tian received his medical degree from Rutgers – Robert Wood Johnson Medical School, New Brunswick, New Jersey. He also received a Masters of Clinical and Translational Science during medical school. He completed internship and residency in Radiation Oncology at Emory University School of Medicine in Atlanta, Georgia.
Dr. Tian is actively involved with multiple areas of clinical research. His research interests include exploring ways of to integrate radiation therapy and immunotherapy, proton therapy, and the use of big data to optimize the multi-disciplinary care of cancer patients. During his training he was principal investigator on a pilot study of functional imaging in the treatment of lung cancer. He is interested in developing clinical trials that investigate how technologic innovations and novel methods of radiation delivery can improve patient outcomes.
Dr. Tian has authored or co-authored over 40 peer-reviewed research articles, which have been published in a number of leading journals including Cancer, International Journal of Radiation Oncology, Biology, Physics, JAMA Oncology. He has given oral presentations at national and international meetings. Dr. Tian has been a peer reviewer for Frontiers in Oncology, Clinical Lung Cancer, Oral Oncology, among others.
Publications Publication Date
During training, Dr. Tian was a recipient of the American Society of Clinical Oncology (ASCO) Conquer Foundation Merit Award at the 2018 annual meeting.